| Phase 3 |
| NCT07315750 |
A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus… |
Gastric Carcinoma |
Recruiting |
| NCT05855200 |
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III… |
Colonic Neoplasms |
Recruiting |
| NCT07389265 |
Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer |
Metastatic Colorectal Cancer (mCRC) |
Recruiting |
| NCT07528209 |
Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally… |
Rectal Cancer |
Recruiting |
| NCT07284849 |
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and… |
CRC (Colorectal Cancer) |
Recruiting |
| NCT06783491 |
Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy… |
Locally Advanced Colorectal Cancer |
Recruiting |
| NCT07472868 |
Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and… |
Locally Advanced Rectal Carcinoma |
Not Yet Recruiting |
| Phase 2/3 |
| NCT06279130 |
Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel… |
Resectable MMR-deficient Solid Tumors |
Recruiting |
| NCT07221357 |
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy… |
Untreated, Unresectable, or Metastatic Colorectal Cancer |
Recruiting |
| NCT07221149 |
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy… |
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma |
Recruiting |
| Phase 2 |
| NCT07294664 |
PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line… |
Advanced Gastric Cancer |
Recruiting |
| NCT07562490 |
A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy… |
ctDNA |
Recruiting |
| NCT07562711 |
Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in… |
ctDNA |
Recruiting |
| NCT05702229 |
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic… |
Gastric Cancer |
Recruiting |
| NCT07314528 |
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal… |
Rectal Cancer Patients |
Not Yet Recruiting |
| NCT06106308 |
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and… |
Metastatic Colorectal Cancer |
Active, Not Recruiting |
| NCT07353827 |
FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for… |
Intrahepatic Cholangiocarcinoma (Icc) |
Not Yet Recruiting |
| NCT07603375 |
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized… |
Esophageal Adenocarcinoma |
Not Yet Recruiting |
| NCT07622017 |
KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer |
Rectal Cancer |
Not Yet Recruiting |
| NCT03781323 |
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally… |
Advanced Rectal Cancer |
Active, Not Recruiting |
| Phase 1/2 |
| NCT07327229 |
A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in… |
Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma |
Recruiting |
| NCT06598007 |
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors |
Solid Tumor, Adult |
Recruiting |
| NCT04068610 |
COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as… |
Metastatic Microsatellite-stable Colorectal Cancer |
Active, Not Recruiting |
| Phase 1 |
| NCT04808323 |
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer |
Rectal Adenocarcinoma |
Recruiting |
| NCT06625775 |
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors |
Solid Tumor, Adult |
Recruiting |